Biopsychosocial self-management was associated with significant but small reductions in disability in patients with acute low back pain.

This Australian study evaluated results of the initial primary care evaluation of 1172 patients (mean age ~ 44 years) with acute low back pain who were enrolled in the inception cohort and followed ...

Spinal manipulation modestly improves pain and function in acute low back pain, a new systematic review and meta-analysis has found. Results were published online April 11 in JAMA. "The principal ...

A randomised controlled trial including 347 participants with lower back or neck pain found there was no benefit of taking opioid pain relievers compared to placebo. There was no significant ...

Despite the risks associated with opioid use, they’re commonly prescribed as a first-line treatment for acute lower back and neck pain. Researchers have found that, compared to opioids, a placebo is ...

Low-back pain and neck pain are common, and the associated health burden is substantial — both economically and in terms of years lived with disability. Although opioid analgesics are not generally ...

A new study revealed that only 10% of non-surgical treatments for low back pain were more effective than a placebo. NSAID drugs, like aspirin and ibuprofen, were most effective for acute pain, while ...

In a recent study published in The Lancet, researchers performed a randomized controlled trial (RCT) in 157 primary care and emergency department (ED) sites across Australia. This study was the first ...

In a recent study published in the Canadian Medical Association Journal, researchers performed a meta-analysis on the clinical course of acute, subacute, and persistent lower back pain. Study: The ...

Lower back pain may resolve within a few days or weeks. However, in some cases, it may last longer. Depending on the cause, back pain may resolve on its own or require treatment. The above information ...

Chronic back pain is the most common type of pain, affecting around 16 million American adults — and now a new study has revealed some discouraging findings about potential treatments. Only around one ...